Date | Insider | Price | Amount |
---|---|---|---|
3-28-2018 Insider Buy |
EW Healthcare Partners, L.P. >10% Owner |
$1.10 CAGR » |
$9,466,956.40 8,606,324 shares |
6-14-2017 Insider Buy |
Nancy Lurker President and CEO |
$1.76 CAGR » |
$99,962.10 56,700 shares |
10-1-2012 Insider Buy |
Paul Hopper Director |
$1.68 CAGR » |
$16,750.00 10,000 shares |
Also See: Institutional Holders of PSDV
Also See: SEC filings
Because the insider purchase was so recent, we don't have a meaningful CAGR result yet; please check back at a later date or use the calculator to examine CAGR over other time periods.
EyePoint Pharmaceuticals Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent EyePoint Pharmaceuticals insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding PSDV
Free PSDV Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Other companies seeing insider buying close in time to when the EyePoint Pharmaceuticals Insider Buying occurred are:
Liberty Media Corp (DE) Insider Buying |